0.6750
+0.0300
+(4.65%)
At close: 8:03:02 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 2M | 1.2M | 13.3M | 7.7M |
| Low Estimate | 2M | 1.2M | 13.3M | 7.7M |
| High Estimate | 2M | 1.2M | 13.3M | 7.7M |
| Year Ago Sales | 447k | 466k | 1.55M | 13.3M |
| Sales Growth (year/est) | 347.43% | 157.51% | 755.86% | -42.11% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4SG.F | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Downgrade | Raymond James: Strong Buy to Outperform | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/22/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Maintains | Raymond James: Strong Buy to Strong Buy | 8/11/2023 |
Related Tickers
GYRE Gyre Therapeutics, Inc.
11.50
+0.17%
ARTV Artiva Biotherapeutics, Inc.
5.40
+0.37%
PEPG PepGen Inc.
1.4400
-21.74%
XBIT XBiotech Inc.
3.6200
+0.28%
LSB LakeShore Biopharma Co., Ltd
2.3800
-6.30%
PASG Passage Bio, Inc.
0.5848
+1.46%
INAB IN8bio, Inc.
0.2479
-7.43%
ALEC Alector, Inc.
1.7200
+4.88%
ENZC Enzolytics, Inc.
0.0009
0.00%
SNDX Syndax Pharmaceuticals, Inc.
14.21
-0.21%